Percheron Therapeutics Limited Share Price BOERSE MUENCHEN
Equities
AWY0
AU0000317281
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0609 EUR | +16.89% | +14.00% | +51.45% |
01:44am | Percheron Therapeutics Names Chief Medical Advisor | MT |
05-29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Sales 2024 * | 3.6M 2.41M 2.21M 188M | Sales 2025 * | 5.3M 3.54M 3.25M 277M | Capitalization | 80.24M 53.63M 49.24M 4.19B |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.36M -10.43M -888M | Net income 2025 * | -31M -20.72M -19.02M -1.62B | EV / Sales 2024 * | 19.8 x |
Net cash position 2024 * | 8.92M 5.96M 5.47M 466M | Net cash position 2025 * | 17.43M 11.65M 10.69M 911M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-5.68
x | P/E ratio 2025 * |
-2.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.66% |
1 week | +14.00% | ||
1 month | +21.73% | ||
3 months | +0.58% | ||
6 months | +45.53% | ||
Current year | +51.45% |
Managers | Title | Age | Since |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 07/05/23 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 08/11/06 |
Anthony Filippis
COO | Chief Operating Officer | - | 31/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 08/11/06 |
Ben Price
BRD | Director/Board Member | 68 | 03/10/21 |
James Garner
CEO | Chief Executive Officer | - | 07/05/23 |
Date | Price | Change |
---|---|---|
03/06/24 | 0.0609 | +16.89% |
31/05/24 | 0.0521 | +8.09% |
30/05/24 | 0.0482 | -1.03% |
29/05/24 | 0.0487 | +2.96% |
28/05/24 | 0.0473 | 0.00% |
Real-time BOERSE MUENCHEN, June 03, 2024 at 04:14 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.44% | 118B | |
+13.74% | 106B | |
-2.35% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.68% | 15.56B | |
+6.41% | 13.63B | |
+29.11% | 12.27B |
- Stock Market
- Equities
- PER Stock
- AWY0 Stock